Non-contraceptive Benefits Of Hormonal And Intrauterine Reversible Contraceptive Methods

dc.creatorBahamondes
dc.creatorLuis; Bahamondes
dc.creatorM. Valeria; Shulman
dc.creatorLee P.
dc.date2015-SEP-OCT
dc.date2016-06-07T13:21:40Z
dc.date2016-06-07T13:21:40Z
dc.date.accessioned2018-03-29T01:41:26Z
dc.date.available2018-03-29T01:41:26Z
dc.identifier
dc.identifierNon-contraceptive Benefits Of Hormonal And Intrauterine Reversible Contraceptive Methods. Oxford Univ Press, v. 21, p. 640-651 SEP-OCT-2015.
dc.identifier1355-4786
dc.identifierWOS:000364331200007
dc.identifier10.1093/humupd/dmv023
dc.identifierhttp://humupd.oxfordjournals.org/content/21/5/640
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/243110
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1306808
dc.descriptionConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.descriptionBACKGROUND: Most contraceptive methods present benefits beyond contraception; however, despite a large body of evidence, many healthcare professionals (HCPs), users and potential users are unaware of those benefits. This review evaluates the evidence for non-contraceptive benefits of hormonal and non-hormonal contraceptive methods. METHODS: We searched the medical publications in PubMed, POPLINE, CENTRAL, EMBASE and LILACS for relevant articles, on non-contraceptive benefits of the use of hormonal and intrauterine reversible contraceptive methods, which were published in English between 1980 and July 2014. Articles were identified using the following search terms: 'contraceptive methods', 'benefits', 'cancer', 'anaemia', 'heavy menstrual bleeding (HMB)', 'endometrial hyperplasia', 'endometriosis' and 'leiomyoma'. RESULTS: We identified, through the literature search, evidence that some combined oral contraceptives have benefits in controlling HMB and anaemia, reducing the rate of endometrial, ovarian and colorectal cancer and ectopic pregnancy as well as alleviating symptoms of premenstrual dysphoric disorder. Furthermore, the use of the levonorgestrel-releasing intrauterine system also controls HMB and anaemia and endometrial hyperplasia and cancer, reduces rates of endometrial polyps in users of tamoxifen and alleviates pain associated with endometriosis and adenomyosis. Depot medroxyprogesterone acetate controls crises of pain associated with sickle cell disease and endometriosis. Users of the etono-gestrel-releasing contraceptive implant have the benefits of a reduction of pain associated with endometriosis, and users of the copper intrauterine device have reduced rates of endometrial and cervical cancer. CONCLUSIONS: Despite the high contraceptive effectiveness of many hormonal and intrauterine reversible contraceptive methods, many HCPs, users and potential users are concerned mainly about side effects and safety of both hormonal and non-hormonal contraceptive methods, and there is scarce information about the many benefits that these methods offer beyond contraception.
dc.description21
dc.description5
dc.description
dc.description640
dc.description651
dc.descriptionConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.descriptionConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.descriptionCNPq [573747/2008-3]
dc.description
dc.description
dc.description
dc.languageen
dc.publisherOXFORD UNIV PRESS
dc.publisher
dc.publisherOXFORD
dc.relationHUMAN REPRODUCTION UPDATE
dc.rightsfechado
dc.sourceWOS
dc.subjectSickle-cell-disease
dc.subjectRandomized-controlled-trial
dc.subjectDepot Medroxyprogesterone Acetate
dc.subjectEndometriosis-associated Pain
dc.subjectEpithelial Ovarian-cancer
dc.subjectPremenstrual Dysphoric Disorder
dc.subjectMyoma-related Menorrhagia
dc.subjectChronic Pelvic Pain
dc.subjectSystem Lng-ius
dc.subjectTerm-follow-up
dc.titleNon-contraceptive Benefits Of Hormonal And Intrauterine Reversible Contraceptive Methods
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución